Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1988-09-01
1989-12-05
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514653, 514766, 514824, 560 56, 560119, 562466, 564222, 564344, A61K 3119
Patent
active
048853143
ABSTRACT:
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) or (II): ##STR1## and pharmaceutically acceptable salts thereof the compounds of the formula (II) in which R.sup.1 is hydrogen are disclosed.
REFERENCES:
patent: 4319039 (1982-03-01), Albers-Schonberg
Kari Hanumath P.
Vyas Kamlesh P.
DiPrima Joseph F.
Hollrah Glennon H.
Merck & Co. , Inc.
Owens Amelia A.
Winokur Melvin
LandOfFree
Novel HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034748